Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trans-tracheal dexmedetomidine versus lidocaine for bronchoalveolar lavage
IRCT20250923067343N3Phase 3Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in None comparing Lidocaine, Dexmedetomidine and Dexmedetomidine + lidocaine (3 arms). Primary endpoints: Sedation score, Cough score and 3 more. Started Jun 2026; status: recruiting.
02
Drugs
dexmedetomidinelidocaine
Beyond the preview
Go deeper on IRCT20250923067343N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250923067343N3.